Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)

Jeong Eun Kim, Joung Soon Jang, Jae Weon Kim, Sung Yong Lee, Chi Heum Cho, Myung Ah Lee, Do Jin Kim, Myung Ju Ahn, Kil Yeon Lee, Sun Jin Sym, Myong Choel Lim, Hun Jung, Cho Eun Kim, Kyung Wan Min

Research output: Contribution to journalComment/debate

Abstract

Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented).

Original languageEnglish
Number of pages1
JournalSupportive Care in Cancer
Volume25
Issue number5
DOIs
Publication statusPublished - 2017 May 1

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)'. Together they form a unique fingerprint.

  • Cite this